Schedule 13G ownership disclosure

BIOXCEL THERAPEUTICS INC

Security class unavailable · CUSIP: 09075P105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.6520%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-18-001857
Form type
SC 13G
Filer
BioXcel Therapeutics, Inc.
CIK
CIK 1720893
Filed
Apr 10, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub